Estimating the survival advantage based on telomere length and serum biomarkers of aging
Abstract Background This study aimed to establish a model that estimates the survival advantage at the molecular level based on telomere length and serum biomarkers of aging, to explore clinical significance. Methods The study consisted of 100 healthy subjects and 40 type 2 diabetes mellitus patient...
Main Authors: | Yilin Zhao, Shijun Li, Hui Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-017-1267-8 |
Similar Items
-
Characteristics of telomere length in patients with hematological diseases (literature review)
by: Yu. A. Kondratieva, et al.
Published: (2021-04-01) -
Telomere Length Measurement by Molecular Combing
by: Vivian F. S. Kahl, et al.
Published: (2020-06-01) -
Newborn telomere length predicts later life telomere length: Tracking telomere length from birth to child- and adulthood
by: Dries S. Martens, et al.
Published: (2021-01-01) -
Telomere Length: A Potential Biomarker for the Risk and Prognosis of Stroke
by: Yanjun Tian, et al.
Published: (2019-06-01) -
Controlling for baseline telomere length biases estimates of the rate of telomere attrition
by: Melissa Bateson, et al.
Published: (2019-10-01)